Current through Register Vol. 49, No. 13, September 23, 2024
Subpart 1.
Specific license
required.
A. Except as provided in item
B, a person may manufacture, produce, acquire, receive, possess, prepare, use,
or transfer radioactive material for medical use only under a specific license
issued by the NRC or an agreement state.
B. A specific license is not needed for an
individual who:
(1) receives, possesses,
uses, or transfers radioactive material according to this chapter under the
supervision of an authorized user as provided under part 4731.4407, unless
prohibited by a license condition; or
(2) prepares unsealed radioactive material
for medical use according to this chapter under the supervision of an
authorized nuclear pharmacist or authorized user as provided under part
4731.4407, unless prohibited by a license condition.
Subp. 2.
Application for
license, amendment, or renewal.
A. An
application for a specific license under subpart 1 must be signed by the
applicant's or licensee's management.
B. An application for a license for medical
use of radioactive materials as described in parts 4731.4404, 4731.4432,
4731.4434, 4731.4440, 4731.4450, 4731.4460, and 4731.4463 must include:
(1) an original application for radioactive
material license form prescribed by the commissioner that includes the facility
diagram, equipment, and training and experience qualifications of the radiation
safety officer, associate radiation safety officers, authorized users,
authorized medical physicists, ophthalmic physicists, and authorized nuclear
pharmacists; and
(2) the
procedures required under parts 4731.4466 and 4731.4472 to 4731.4474, as
applicable.
C. A request
for a license amendment or renewal must include:
(1) an original of the form prescribed by the
commissioner under item B or a letter requesting the amendment or renewal
containing all the information in the form prescribed by the commissioner under
item B; and
(2) the procedures
required under parts 4731.4466 and 4731.4472 to 4731.4474, as
applicable.
D. In
addition to the requirements under items B and C, an application for a license
or amendment for medical use of radioactive material under part 4731.4404 must
include:
(1) information regarding any
radiation safety aspects of the medical use of the material that is not
addressed in, or differs from, parts 4731.4400 to 4731.4427 and 4731.4500 to
4731.4528;
(2) identification of
and commitment to follow the applicable radiation safety program requirements
in parts 4731.4432 to 4731.4479 that are appropriate for the specific medical
use;
(3) any additional specific
information on:
(a) radiation safety
precautions and instructions;
(b)
methodology for measurement of dosages or doses to be administered to patients
or human research subjects; and
(c) calibration, maintenance, and repair of
instruments and equipment necessary for radiation safety; and
(4) any other information
requested by the commissioner for review of the application.
E. An applicant that satisfies the
requirements under part 4731.3530 may apply for a Type A specific license of
broad scope.
Subp. 3.
License amendments. A licensee must apply for and receive a
license amendment:
A. before the licensee
receives, prepares, or uses radioactive material for a type of use that is
permitted under this chapter, but not authorized under the licensee's current
license issued under parts 4731.4400 to 4731.4527;
B. before the licensee permits anyone to work
as an authorized user, authorized nuclear pharmacist, authorized medical
physicist, or ophthalmic physicist under the license, except that the licensee
may permit an individual to work as an authorized user, authorized nuclear
pharmacist, authorized medical physicist, or ophthalmic physicist for 60 days
before being authorized on a license if the individual is an authorized user,
authorized nuclear pharmacist, authorized medical physicist, or ophthalmic
physicist for the same type of use:
(1) on a
license issued by the commissioner, the NRC, or an agreement state or on an
equivalent permit or license recognized by the commissioner, the NRC, or an
agreement state that authorizes the use of radioactive material in medical use
or in the practice of nuclear pharmacy;
(2) on a permit issued by a commissioner,
NRC, or agreement state specific licensee of broad scope that is authorized to
permit the use of radioactive material in medical use or in the practice of
nuclear pharmacy;
(3) on a permit
issued by an NRC master material licensee that is authorized to permit the use
of radioactive material in medical use or in the practice of nuclear pharmacy;
or
(4) by a commercial nuclear
pharmacy that has been authorized to identify authorized nuclear pharmacists;
C. before the licensee
changes radiation safety officers, except as provided under part 4731.4405,
subpart 1, item C;
D. before the
licensee permits anyone to work as an associate radiation safety officer, or
before the radiation safety officer assigns duties and tasks to an associate
radiation safety officer that differ from those for which this individual is
authorized on the license;
E.
before the licensee receives radioactive material in excess of the amount or in
a form different than authorized in the license or before the licensee receives
a radionuclide that is different than the radionuclide authorized in the
license;
F. before the licensee
adds or changes the areas of use identified in the application or in the
license, except for areas of use where radioactive material is used only
according to part 4731.4432 or 4731.4434;
G. before the licensee changes an address identified
in the application or on the license;
H. before the licensee revises procedures required
under parts 4731.4466 and 4731.4472 to 4731.4474, as applicable, when the
revision reduces radiation safety; and
I. before the licensee receives a sealed
source from a different manufacturer or of a different model number than
authorized by its license unless the sealed source is used for manual
brachytherapy, is listed in the Sealed Source and Device Registry, and is in a
quantity and for an isotope authorized by the license. If a licensee obtains a
sealed source in accordance with this item, the licensee must submit an
amendment request to add the sealed source to their radioactive materials
license within 30 days after receiving the source.
Subp. 4.
Notifications of
changes.
A. A licensee must notify the
commissioner by letter no later than 30 days after:
(1) an authorized user, authorized nuclear
pharmacist, radiation safety officer, associate radiation officer, authorized
medical physicist, or ophthalmic physicist has a name change;
(2) the licensee's mailing address
changes;
(3) the licensee's name
changes, but the name change does not constitute a transfer of control of the
license as described under part 4731.3075, subpart 2;
(4) the licensee has added to or changed the
areas of use identified in the application or license where radioactive
material is used according to part 4731.4432 or 4731.4434;
(5) the licensee permits an individual
qualified to be a radiation safety officer under parts 4731.4411 and 4731.4415,
to function as a temporary radiation safety officer and to perform the
functions of a radiation safety officer as described under part 4731.4405,
subpart 1, item C; or
(6) the
licensee permits an individual to work under the provisions of subpart 3, item
B, as an authorized user, authorized medical physicist, ophthalmic physicist,
or authorized nuclear pharmacist prior to being added to the license. The
notification must include a copy of the commissioner, NRC, or agreement state
license, the permit issued by an NRC master material licensee, the permit
issued by a commissioner, NRC, or agreement state licensee of broad scope, or
the permit issued by an NRC master material license broad scope permittee.
B. A licensee must mail
required documents to the address under part 4731.0200, subpart
4.
Subp. 5.
Exemptions; broad scope license. A licensee possessing a Type A
specific license of broad scope for medical use, issued under parts 4731.3500
to 4731.3580, is exempt from:
A. subpart 2,
item D, regarding the need to file an amendment to the license for medical use
of radioactive materials under part 4731.4404;
B. subpart 3, item B;
C. subpart 3, item F, regarding additions to
or changes in the areas of use at the addresses identified in the application
or license;
D. subpart 4, item A,
subitem (1), for an authorized user, authorized nuclear pharmacist, authorized
medical physicist, or ophthalmic physicist;
E. subpart 4, item A, subitem (4), regarding
additions to or changes in the areas of use identified in the application or
license where radioactive material is used under part 4731.4432 or 4731.4434;
and
F. part 4731.4410, item
A.
Subp. 6.
License
issuance.
A. The commissioner shall
issue a license for the medical use of radioactive material if:
(1) the applicant complies with subpart
2;
(2) the applicant pays any
applicable fee as provided under Minnesota Statutes, section
144.1205;
(3) the commissioner finds the applicant
equipped and committed to observe the safety standards established by the
commissioner in this chapter for the protection of the public health and
safety; and
(4) the applicant meets
the requirements of parts 4731.3000 to 4731.3175.
B. The commissioner shall issue a license for
mobile medical services if the applicant:
(1)
meets the requirements under item A; and
(2) ensures that individuals or human
research subjects to whom unsealed radioactive material or radiation from
implants containing radioactive material will be administered are released
following treatment according to part 4731.4427.
Subp. 7.
Specific
exemptions.
The commissioner may, upon application of any interested
person or upon the commissioner's own initiative, grant exemptions from parts
4731.4400 to 4731.4527 that the commissioner determines are authorized by law
and will not endanger life or property or the common defense and security and
are otherwise in the public interest.
Statutory Authority: MS s
144.1202;
144.1203